Cite
HARVARD Citation
Hauck, S. et al. (n.d.). Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma. European journal of cancer. pp. S18-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hauck, S. et al. (n.d.). Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma. European journal of cancer. pp. S18-. [Online].